Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants

Author:

Ozawa Tatsuhiko1ORCID,Tani Hideki2ORCID,Anraku Yuki3ORCID,Kita Shunsuke3ORCID,Igarashi Emiko2,Saga Yumiko2,Inasaki Noriko2,Kawasuji Hitoshi4,Yamada Hiroshi5ORCID,Sasaki so-Ichiro6,Somekawa Mayu5ORCID,Sasaki Jiei7,Hayakawa Yoshihiro6ORCID,Yamamoto Yoshihiro4ORCID,Morinaga Yoshitomo5ORCID,Kurosawa Nobuyuki8ORCID,Isobe Masaharu8ORCID,Fukuhara Hideo3ORCID,Maenaka Katsumi3ORCID,Hashiguchi Takao7ORCID,Kishi Hiroyuki1ORCID,Kitajima Isao9ORCID,Saito Shigeru9ORCID,Niimi Hideki10ORCID

Affiliation:

1. Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan

2. Department of Virology, Toyama Institute of Health, Toyama, Japan

3. Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan

4. Department of Clinical Infectious Diseases, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan

5. Department of Microbiology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan

6. Section of Host Defences, Department of Bioscience, Institute of Natural Medicine, University of Toyama, Japan

7. Laboratory of Medical Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan

8. Department of Life Sciences and Bioengineering, Laboratory of Molecular and Cellular Biology, Faculty of Engineering, Academic Assembly, University of Toyama, Toyama, Japan

9. Administrative office, University of Toyama, Toyama, Japan

10. Department of Clinical Laboratory and Molecular Pathology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan

Funder

Discretionary Fund of the President of the University of Toyama

Ministry of Education, Culture, Sports, Science and Technology

Toyama Pharmaceutical Valley Development Consortium

Takeda Foundation

Kyoto University

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3